CytomX Therapeutics Stock Forecast
Weaker technical forecast for CytomX Therapeutics as stock downgraded to Strong Sell Candidate.
(Updated on Apr 25, 2024)
The CytomX Therapeutics stock price fell by -1.84% on the last day (Thursday, 25th Apr 2024) from $1.63 to $1.60. During the last trading day the stock fluctuated 3.54% from a day low at $1.58 to a day high of $1.64. The price has fallen in 7 of the last 10 days and is down by -25.58% for this period. Volume has increased on the last day by 7 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 286 thousand shares were bought and sold for approximately $458.06 thousand.
Given the current short-term trend, the stock is expected to rise 17.41% during the next 3 months and, with a 90% probability hold a price between $1.88 and $3.53 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
CTMX Signals & Forecast
There are few to no technical positive signals at the moment. The CytomX Therapeutics stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.68 and $2.06. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, March 04, 2024, and so far it has fallen -41.61%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). CytomX Therapeutics gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".
Support, Risk & Stop-loss for CytomX Therapeutics stock
CytomX Therapeutics finds support from accumulated volume at $1.53 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.0560 between high and low, or 3.54%. For the last week, the stock has had daily average volatility of 5.24%.
CytomX Therapeutics is oversold on RSI14 (18). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (CTMX) For The Upcoming Trading Day Of Friday 26th
For the upcoming trading day on Friday, 26th we expect CytomX Therapeutics to open at $1.61, and during the day (based on 14 day Average True Range), to move between $1.48 and $1.72, which gives a possible trading interval of +/-$0.125 (+/-7.80%) up or down from last closing price. If CytomX Therapeutics takes out the full calculated possible swing range there will be an estimated 15.59% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $1.65 (3.12%) than the support at $1.53 (4.38%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is CytomX Therapeutics stock A Buy?
The CytomX Therapeutics stock holds several negative signals and despite the positive trend, we believe CytomX Therapeutics will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.
Current score: -5.108 Strong Sell Candidate Downgraded
Predicted Opening Price for CytomX Therapeutics of Friday, April 26, 2024
Fair opening price April 26, 2024 | Current price |
---|---|
$1.61 ( 0.333%) | $1.60 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for CTMX
Fibonacci Support & Resistance Levels
Level | Price | |||
---|---|---|---|---|
Resistance | R3 | 1.66 | 3.83 % | |
R2 | 1.64 | 2.50 % | ||
R1 | 1.63 | 1.67 % | ||
Current price: | 1.60 | |||
Support | S1 | 1.58 | -1.00 % | |
S2 | 1.57 | -1.83 % | ||
S3 | 1.55 | -3.17 % |
Accumulated Volume Support & Resistance Levels
Level | Price | |||
---|---|---|---|---|
Resistance | R3 | 1.76 | 10.00 % | |
R2 | 1.67 | 4.37 % | ||
R1 | 1.65 | 3.12 % | ||
Current price | 1.60 | |||
Support | S1 | 1.53 | -4.38% | |
S2 | 1.50 | -6.25% | ||
S3 | 1.41 | -11.88% |
FAQ
Click here for our free guide on how to buy CytomX Therapeutics Stock.